Sphingosine kinase 1 and cancer: a systematic review and meta-analysis.
about
Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor MicroenvironmentIdentification of Biomarkers for Breast Cancer Using Databases.Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patientsTumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1.Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget.Sphingosine kinase 1 as an anticancer therapeutic target.Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer.Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo.Discovering Pair-wise Synergies in Microarray DataEssential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer.Sphingosine kinase 1 is overexpressed and promotes adrenocortical carcinoma progressionSphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2.Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.Sphingolipids and mitochondrial apoptosis.Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer.Metabolic Regulation of Apoptosis in Cancer.Targeting sphingosine-1-phosphate signaling for cancer therapy.Hispidulin suppresses tumor growth and metastasis in renal cell carcinoma by modulating ceramide-sphingosine 1-phosphate rheostat.SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models."Dicing and Splicing" Sphingosine Kinase and Relevance to Cancer.Inhibition of dihydroceramide desaturase activity by the sphingosine kinase inhibitor SKI II.Sphingosine-1-phosphate transporters as targets for cancer therapy.Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo.Sphingolipid metabolism in cancer signalling and therapy.Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation.RNA sequencing reveals widespread transcriptome changes in a renal carcinoma cell line.
P2860
Q28069459-2EAB0F74-6C5B-42BA-91F2-8CB3F1D8CC5AQ30239810-B74C2F9E-8009-477A-956A-5F1356D5B561Q30278883-E85ED679-C25C-4E97-AEFD-53E561440F63Q31112933-98CF9C72-5878-4C26-B79A-4CDF531918BBQ33607086-D793F120-8956-4257-B8DE-E49379B57FF1Q33829692-BDF4E095-99B4-4288-8742-4654B6239D15Q35794452-4A151D48-AE67-4D28-BEC6-2D14AE8F506BQ35817821-45400BC0-B19C-486C-AA07-FFB938ACB6EEQ36027371-AE77E940-35E9-4714-AA3E-D36FBAFD4883Q36089234-A64BD678-146F-4239-AFB8-A9F05866A4D1Q36748690-79B66259-C0DF-48AD-9140-2A9A380FD4D6Q36772101-7810B897-5FFC-481F-B02F-F50773BD095CQ36782379-35BEB5B4-8DED-42DB-ABF8-9CB8658D8D3FQ36886386-1D8FCC1D-59C5-429E-8EC5-923E5B44F8B5Q37697046-64899221-967B-4D4C-B97A-6B5103F0A994Q38332040-5A1A254B-8F63-420D-BB96-4CFCA450BFEFQ38880225-A1F5B9F9-A99C-461F-AEC9-6CB14F1B2D9DQ38909416-9637CF9C-FCD6-4A6F-A0EA-4272CC2D5F2BQ38937332-416F72E9-5CF3-4621-A846-517B5794E3E1Q38969211-4D231B5C-BC07-4B3F-A1BE-2D91B71873FCQ39379449-6D8E974A-6164-4F85-A93A-AD6834D789E2Q41098262-8EC7DF45-A345-4320-A159-2B2DC2E3DEF7Q41521563-925206A8-7173-4ACA-B923-D815FCF71B8BQ41661043-33FEB8E7-4942-46FC-AE73-947B4374689EQ41828412-C37A7388-81E9-4F36-BBFD-D8A44219D307Q42181059-1BB2A18E-04AA-4ACE-BD83-88ECF5BE72D4Q47167981-BBD72D85-0ADD-4EE5-99B5-AA866FDF4754Q49950035-AAF501E8-BD63-4F58-842F-BC1FEA60DE98Q50098292-C851D95A-65D8-4804-A5DF-8D17F381B452Q52729737-73300DE1-2E8F-4361-BD89-F02C06BBC8F2
P2860
Sphingosine kinase 1 and cancer: a systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sphingosine kinase 1 and cancer: a systematic review and meta-analysis.
@ast
Sphingosine kinase 1 and cancer: a systematic review and meta-analysis.
@en
type
label
Sphingosine kinase 1 and cancer: a systematic review and meta-analysis.
@ast
Sphingosine kinase 1 and cancer: a systematic review and meta-analysis.
@en
prefLabel
Sphingosine kinase 1 and cancer: a systematic review and meta-analysis.
@ast
Sphingosine kinase 1 and cancer: a systematic review and meta-analysis.
@en
P2093
P2860
P31
P1433
P1476
Sphingosine kinase 1 and cancer: a systematic review and meta-analysis.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0090362
P407
P50
P5008
P577
2014-02-27T00:00:00Z